Literature DB >> 738420

The timing of cyclophosphamide therapy in tumor-bearing rats affects the resistance to tumor challenge in survivors.

M Marusić, N Allegretti, F Culo.   

Abstract

Cyclophosphamide given to rats 2 or 5 days after an injection of Yoshida ascites sarcoma cured approximately the same proportion of animals, but the resistance to a subsequent tumor challenge was found only in rats treated with the drug 5 days after tumor injection.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 738420     DOI： 10.1007/bf01981468

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  3 in total

1.  Antitumor activity of cytoxan.

Authors:  K SUGIURA; F A SCHMID; M M SCHMID
Journal:  Cancer Res       Date:  1961-11       Impact factor: 12.701

2.  Hematopoietic recovery after large doses of cyclophosphamide: correlation of proliferative state with sensitivity.

Authors:  W D DeWys; A Goldin; N El
Journal:  Cancer Res       Date:  1970-06       Impact factor: 12.701

Review 3.  Symposium on immunosuppressive drugs. Immunosuppressive drugs. I.

Authors:  G W Santos
Journal:  Fed Proc       Date:  1967 May-Jun
  3 in total
  1 in total

1.  Interference of anti-tumor and immunosuppressive effects of cyclophosphamide in tumor-bearing rats. Analysis of factors determining resistance or susceptibility to a subsequent tumor challenge.

Authors:  D Vidović; M Marusić; F Culo
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.